BUZZ-Citi initiates coverage on Australia's Atlas Arteria with "buy"

Reuters
20 Nov 2024

** Citi initiates coverage on international toll road operator Atlas Arteria with "Buy" rating at price target of A$5.80

** Brokerage says ALX is attractive due to its 8% dividend per share yield and projected strong free cash growth of 14-15% in FY24-FY25

** Citi considers the stock undervalued, as it's priced at an implied 5-7x EV/EBITDA, a ratio comparing the company's value including debt to its cash earnings

** Citi sees potential value increase from ending profit distribution restrictions at Dulles Greenway in the U.S. and a possible company acquisition

** Brokerage flags caution on potential additional taxes on APRR, a French toll road in which ALX owns a ~30% stake, which could impact profitability

** Stock has lost ~16.4% so far this year as of the last close

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10